Search research articles
Contact Us
Filters
Showing results (101-110 of 106) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 106 results.
Arzneimittel-Forschung
|
February 5, 1998
Randomised, double-blind, placebo-controlled study of pivagabine in neurasthenia
G Pizzolato, A Cagnin, D Mancia, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
January 29, 2013
Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases
A Ghezzi, P Annovazzi, E Cocco, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
July 21, 2010
Three years of experience: the Italian registry and safety data update
G L Mancardi, G Tedeschi, M P Amato, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
November 3, 2009
The pharmacovigilance program on natalizumab in Italy: 2 years of experience
G Tedeschi, M P Amato, R D'Alessandro, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
January 15, 2011
Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group--Italian Neurological Society
A Ghezzi, L M E Grimaldi, M G Marrosu, et al.
International Journal of Immunopathology and Pharmacology
|
July 10, 2014
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy
R Totaro, A Lugaresi, P Bellantonio, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 106) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 106 results.
Arzneimittel-Forschung
|
February 5, 1998
Randomised, double-blind, placebo-controlled study of pivagabine in neurasthenia
G Pizzolato, A Cagnin, D Mancia, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
January 29, 2013
Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases
A Ghezzi, P Annovazzi, E Cocco, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
July 21, 2010
Three years of experience: the Italian registry and safety data update
G L Mancardi, G Tedeschi, M P Amato, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
November 3, 2009
The pharmacovigilance program on natalizumab in Italy: 2 years of experience
G Tedeschi, M P Amato, R D'Alessandro, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
January 15, 2011
Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group--Italian Neurological Society
A Ghezzi, L M E Grimaldi, M G Marrosu, et al.
International Journal of Immunopathology and Pharmacology
|
July 10, 2014
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy
R Totaro, A Lugaresi, P Bellantonio, et al.
Page
of 11